GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » Net Cash per Share

AK Medical Holdings (HKSE:01789) Net Cash per Share : HK$0.11 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). AK Medical Holdings's Net Cash per Share for the quarter that ended in Dec. 2023 was HK$0.11.

The historical rank and industry rank for AK Medical Holdings's Net Cash per Share or its related term are showing as below:

HKSE:01789' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 7.82   Med: 22.76   Max: 67.54
Current: 49.36

During the past 10 years, the highest Price-to-Net-Cash Ratio of AK Medical Holdings was 67.54. The lowest was 7.82. And the median was 22.76.

HKSE:01789's Price-to-Net-Cash is ranked worse than
90.28% of 319 companies
in the Medical Devices & Instruments industry
Industry Median: 6.87 vs HKSE:01789: 49.36

AK Medical Holdings Net Cash per Share Historical Data

The historical data trend for AK Medical Holdings's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings Net Cash per Share Chart

AK Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.44 0.29 0.51 0.11

AK Medical Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.38 0.51 0.07 0.11

Competitive Comparison of AK Medical Holdings's Net Cash per Share

For the Medical Devices subindustry, AK Medical Holdings's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AK Medical Holdings's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where AK Medical Holdings's Price-to-Net-Cash falls into.



AK Medical Holdings Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

AK Medical Holdings's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(794.818-668.431-0)/1121.9
=0.11

AK Medical Holdings's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(794.818-668.431-0)/1121.9
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AK Medical Holdings  (HKSE:01789) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


AK Medical Holdings Net Cash per Share Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


AK Medical Holdings (HKSE:01789) Business Description

Traded in Other Exchanges
N/A
Address
No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200
AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.
Executives
Li Zhijiang
Trident Trust Company (hk) Limited
Ximalaya Limited
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd. 2102 Investment manager
Suntop Limited 2101 Beneficial owner
Zhang Chaoyang 2307 Founder of a discretionary trust who can infl
Bamboo Group Management Limited 2201 Interest of corporation controlled by you
Zhang Bin 2202 Interest of your spouse
Rainbow Holdings Limited 2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner
Orbimed Advisors Ii Limited
Orbimed Asia Gp Ii, L.p.
Orbimed Asia Partners Ii, L.p.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines